About the Company
We do not have any company description for Pacira BioSciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PCRX News
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 23rd ...
Pacira BioSciences (NASDAQ:PCRX) stock falls 4.1% in past week as three-year earnings and shareholder returns continue downward trend
During the three years that the share price fell, Pacira BioSciences' earnings per share (EPS) dropped by 36% each year. In comparison the 26% compound annual share price decline isn't as bad as the ...
Pacific Biosciences of California (PACB) Price Target Decreased by 18.15% to 9.01
The average one-year price target for Pacific Biosciences of California (NasdaqGS:PACB) has been revised to 9.01 / share.
Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc
Los Angeles, CA, March 28, 2024 (GLOBE NEWSWIRE) -- Endonovo (OTC PINK: ENDV) and its subsidiary, SofPulse, Inc., today announced they have finalized and completed the Asset Purchase Agreement (APA), ...
Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides
Under the terms of the research collaboration extension, Sentia and Neurocrine will continue to work together to discover novel peptide antagonists targeting CRF and advance them to development ...
Loading the latest forecasts...